Advances in Drug-induced Diseases, volume II

238.7K

views

280

authors

47

articles

Advances in Drug-induced Diseases, volume II

238.7K

views

280

authors

47

articles

Editors

6

Yao Liu

Daping Hospital

Patricia Moriel

State University of Campinas

Linan Zeng

McMaster University

Jia-bo Wang

School of Traditional Chinese Medicine, Capital Medical University

Miao Yan

Department of Pharmacy, Second Xiangya Hospital, Central South University

Maxine Deborah Gossell-Williams

University of the West Indies, Mona

Impact

Fetching...

About

This Research Topic is part of a series with:

Advances in Drug-induced Diseases: Volume I

Drug-induced diseases are adverse effects of drugs that are serious enough for patients. A new drug’s safety profile generally has been fully defined prior to its approval. Unfortunately, some severe adverse drug reactions (ADRs), which appear at very low frequencies, appear when the drug is exposed to a large population. These severe ADRs, that is, drug-induced diseases, should be noticed. Pharmacovigilance is well established in many countries to avoid or minimize the harm of drugs. Spontaneous reporting system developed to collect reports of suspicious ADRs is an essential part of pharmacovigilance. In addition, database studies, risk management plans, and warnings are also used to uncover new ADRs. However, ADRs are still vastly underreported across healthcare settings and sectors, including severe ADRs. Additional activities and strategies are expected to help recognize ADRs and reduce drug-induced diseases.

This Research Topic aims to make a clinical and basic profile of drug-induced diseases, including the epidemiology, mechanism, and outcome. It is also devoted to uncovering new ADRs, especially rare or serious ones. We will explore the reason that causes drug-induced diseases, such as drug-drug interactions, drug metabolism and transport, and the genetic basis of individuals. Furthermore, this topic encourages researchers to report new strategies to deal with drug-induced diseases and help authorities build policies to reduce drug-induced diseases.

We encourage authors to submit Original Research, Systematic Review, Review, Opinion, and Perspective articles, in the following subtopics, but not limited to:

• Assess the epidemiology of ADRs and drug-induced diseases

• Monitor the clinical safety problems associated with the use of medications

• Monitor drug-drug interactions to avoid preventable medication errors

• Explore the relationship between drug-induced diseases and drug metabolism and transport

• Investigate the genetic basis of inter individual differences in ADRs

• Evaluate the impact of the strategies to reduce the harm of medication

• Evaluate the knowledge and attitude of the health care professionals about ADRs

In addition, the research will be considered for peer-review only if the drug is registered and available to be used.

Download ebook

PDF

EPUB

Share

Editors

Yao Liu

Daping Hospital

Patricia Moriel

State University of Campinas

Linan Zeng

McMaster University

Jia-bo Wang

School of Traditional Chinese Medicine, Capital Medical University

Miao Yan

Department of Pharmacy, Second Xiangya Hospital, Central South University

Maxine Deborah Gossell-Williams

University of the West Indies, Mona

Impact

238,653 Total views

169,350 Article views

50,667 Article downloads

18,636 Topic views

Published In

Frontiers in Pharmacology

Gastrointestinal and Hepatic Pharmacology, Pharmacology of Anti-Cancer Drugs, Pharmacology of Infectious Diseases, Pharmacoepidemiology

Frontiers in Oncology

Pharmacology of Anti-Cancer Drugs

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic